Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 21.
doi: 10.1097/INF.0000000000004950. Online ahead of print.

Urinary Cytomegalovirus Load at Birth as a Predictor of Sequelae in Congenital Cytomegalovirus Infection

María Ríos-Barnés  1   2 , Roberto Pedrero  3 , Clàudia Fortuny  1   2   3   4 , Maria Dolores Folgueira  5   6   7 , Marie Antoinette Frick  8 , Beatriz Álvarez-Vallejo  8 , Fernando Baquero-Artigao  9   10 , Paula Rodriguez-Molino  9   10 , Almudena Alonso-Ojembarrena  11 , Clotilde Fernández Gutiérrez Del Álamo  12 , Oihana Muga  13 , Itziar Sota  13 , Jesús Saavedra-Lozano  10   14 , Rut Del Valle  15 , María Malumbres  16 , Elena Colino  17 , Ana Menasalvas  18 , Elisa Garrote  19 , Ana Alarcón  20 , Daniel Blázquez-Gamero  21 , Antoni Noguera-Julian  6   7   8   10 ; Spanish Registry of Children With Congenital Cytomegalovirus Infection (REDICCMV).
Affiliations

Urinary Cytomegalovirus Load at Birth as a Predictor of Sequelae in Congenital Cytomegalovirus Infection

María Ríos-Barnés et al. Pediatr Infect Dis J. .

Abstract

Background: Congenital cytomegalovirus infection (cCMV) is the most common congenital infection worldwide. Identifying early prognostic markers of sequelae is crucial for improving follow-up protocols, especially for asymptomatic patients at birth. We aimed to determine the association of urine cytomegalovirus (CMV) viral load (VL) at birth with symptomatic disease and the development of sequelae in a cohort of Spanish patients with cCMV.

Methods: Patients for whom a positive quantitative CMV urine VL was available in the neonatal period were included. Exclusion criteria were urine VL performed beyond day 28 of life, having initiated antiviral treatment and concomitant primary or secondary immunodeficiency disorders. Sequelae were assessed in children with at least 6 months of follow-up.

Results: Overall, 357 patients were included and sequelae were assessed in 282 (79.0%). At birth, 30.2% were asymptomatic, 11.8% had mild and 58.0% had moderate-to-severe cCMV disease. Higher urine CMV VL at birth was associated with thrombocytopenia, chorioretinitis and neuroimaging abnormalities, but not with disease severity. At the last available follow-up (median age: 30.1 months), 68 (24.1%) children presented with sequelae, mainly sensorineural hearing loss (n = 60). Sequelae were more common among children with moderate-to-severe cCMV disease at birth. In multivariate analysis, hepatomegaly [adjusted odds ratios (aOR): 7.9, 95% confidence intervals (CI): 1.5-63.3], hypotonia (aOR: 4.4, 95% CI: 1.2-18.3), abnormalities in cranial ultrasound (aOR: 3.3, 95% CI: 1.9-5.7) and urine CMV VL at birth (aOR: 1.3 per 1 log10 increase, 95% CI: 1.1-1.6) were associated with a higher risk of sequelae.

Conclusions: Urine CMV VL at birth was associated with some symptoms and signs of cCMV and positively correlated with the risk of sequelae.

Keywords: congenital cytomegalovirus infection; sensorineural hearing loss; sequelae; urine viral load; valganciclovir.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

References

    1. Liberati C, Sturniolo G, Brigadoi G, et al. Burden of congenital CMV infection: a narrative review and implications for public health interventions. Viruses. 2024;16:1311.
    1. Blázquez-Gamero D, Soriano-Ramos M, Vicente M, et al.; for PICCSA Study Group. Prevalence and clinical manifestations of congenital cytomegalovirus infection in a screening program in Madrid (PICCSA study). Pediatr Infect Dis J. 2020;39:1050–1056.
    1. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17:253–276.
    1. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17:355–363.
    1. Dreher AM, Arora N, Fowler KB, et al. Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection. J Pediatr. 2014;164:855–859.

LinkOut - more resources